The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...

Researchers said the drugs could make a major difference for chronic kidney disease patients by helping to reduce other risk ...

The Biden administration on Tuesday proposed requiring Medicare and Medicaid to cover weight loss drugs like Wegovy and ...

The glucose-lowering and weight-reducing drug class appears to benefit the heart and kidneys in people with lupus and lupus nephritis, independently of glucose-lowering and weight loss.

The Biden administration is proposing to expand coverage of anti-obesity medicines for those with Medicare and Medicaid.

California-based BridgeBio has secured US FDA approval for its lead candidate drug, acoramidis (brand name Attruby) for ...

While we wait for scientists to come up with a miracle pill, we can take matters into our own hands with easy steps to ensure ...

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...

Those who engage in 'bed rotting' may face a higher risk of type 2 diabetes, which is associated with an inactive lifestyle, ...